Although this pathway is known to promote melanoma phenotype switching/dedifferentiation (Sun et al,2014), to support melanoma growth (Berking et al,2001) and metastasis, little is known about the role of SMAD3 in melanoma biology and as a modulator of resistance to targeted therapy. This evidence concerns the gene SMAD3 and melanoma.